(Q45446011)

English

IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes

scientific article published in July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

Mikel Zaratiegui

7

1 reference

Europe PubMed Central

14 December 2017

10

1 reference

Europe PubMed Central

14 December 2017

Fernando Rotellar

object named as

Fernando Rotellar

4

0 references

author name string

Pedro Berraondo

1

1 reference

Europe PubMed Central

14 December 2017

Laura Ochoa

2

1 reference

Europe PubMed Central

14 December 2017

Julien Crettaz

3

1 reference

Europe PubMed Central

14 December 2017

Africa Vales

5

1 reference

Europe PubMed Central

14 December 2017

Eduardo Martínez-Ansó

6

1 reference

Europe PubMed Central

14 December 2017

Juan Ruiz

8

1 reference

Europe PubMed Central

14 December 2017

Gloria González-Aseguinolaza

9

1 reference

Europe PubMed Central

14 December 2017

publication date

1 July 2005

1 reference

Europe PubMed Central

14 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

14 December 2017

12

1 reference

Europe PubMed Central

14 December 2017

1

1 reference

Europe PubMed Central

14 December 2017

68-76

1 reference

Europe PubMed Central

14 December 2017

Viral hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Chronic hepatitis B: update of recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Pegylated interferons for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Clinical gene transfer studies for hemophilia B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

The woodchuck: an animal model for hepatitis B virus infection in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

The woodchuck interferon-alpha system: Cloning, family description, and biologic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Autoimmune anemia in macaques following erythropoietin gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Erythropoietin gene therapy leads to autoimmune anemia in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Improved production of recombinant AAV by transient transfection of NB324K cells using electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Novel tools for production and purification of recombinant adenoassociated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.02.017

7 January 2021

Identifiers

10.1016/J.YMTHE.2005.02.017

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45446011&oldid=2076958532"